Zoetis Inc. (ZTS) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of S&P 500

Zoetis Inc. (ZTS) closed at USD 75.29 on 2026-10-14, a change of -47.2 % over the past year, with a market capitalization of USD 32.4B.

Zoetis Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Zoetis Inc. key figures

Previous close

USD 75.29 (2026-10-14)

1-year change

-47.2 %

Market cap

USD 32.4B

Enterprise value

USD 39.98B

P/E ratio (trailing)

12.90

P/E ratio (forward)

11.98

EPS (trailing)

6.08

EPS (forward)

6.54

PEG ratio

14.01

Price to book

10.32

Revenue growth

-0.2 %

Earnings growth

1.2 %

Dividend per share (trailing)

2.06

Short ratio

4.02

Employees

14,500

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Zoetis Inc. and compare it with other stocks.